Trials / Conditions / EGFR Positive Solid Tumor
EGFR Positive Solid Tumor
3 registered clinical trials studyying EGFR Positive Solid Tumor.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular I NCT04106167 | Fate Therapeutics | — |
| Completed | FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumo NCT03841110 | Fate Therapeutics | Phase 1 |
| Completed | FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors NCT03319459 | Fate Therapeutics | Phase 1 |